ESRP1 and breast carcinoma: In addition, overexpression of ESRP1 and ESRP2 in basal-like breast cancer cells resulted in upregulation of E-cadherin expression, while in an ER-negative breast cancer model (MDA-MB-231 cells), low ESRP1 expression was associated with the development of EMT.